{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T18:34:26Z","timestamp":1767983666352,"version":"3.49.0"},"reference-count":20,"publisher":"American Society for Microbiology","issue":"11","license":[{"start":{"date-parts":[[2003,6,1]],"date-time":"2003-06-01T00:00:00Z","timestamp":1054425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[2003,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>The emergence of circulating vaccine-derived poliovirus (cVDPV) strains in suboptimally vaccinated populations is a serious threat to the global poliovirus eradication. The genetic determinants for the transmissibility phenotype of polioviruses, and in particularly of cVDPV strains, are currently unknown. Here we describe the fecal excretion of wild-type poliovirus, oral polio vaccine, and cVDPV (Hispaniola) strains after intraperitoneal injection in poliovirus receptor-transgenic mice. Both the pattern and the level of fecal excretion of the cVDPV strains resemble those of wild-type poliovirus type 1. In contrast, very little poliovirus was present in the feces after oral polio vaccine administration. This mouse model will be helpful in elucidating the genetic determinants for the high fecal-oral transmission phenotype of cVDPV strains.<\/jats:p>","DOI":"10.1128\/jvi.77.11.6541-6545.2003","type":"journal-article","created":{"date-parts":[[2003,5,12]],"date-time":"2003-05-12T22:33:05Z","timestamp":1052778785000},"page":"6541-6545","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":13,"title":["Excretion of Wild-Type and Vaccine-Derived Poliovirus in the Feces of Poliovirus Receptor-Transgenic Mice"],"prefix":"10.1128","volume":"77","author":[{"given":"Hein J.","family":"Boot","sequence":"first","affiliation":[{"name":"Laboratory for Vaccine-Preventable Diseases, National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720 BA Bilthoven, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniella T. J.","family":"Kasteel","sequence":"additional","affiliation":[{"name":"Laboratory for Vaccine-Preventable Diseases, National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720 BA Bilthoven, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Marie","family":"Buisman","sequence":"additional","affiliation":[{"name":"Laboratory for Vaccine-Preventable Diseases, National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720 BA Bilthoven, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tjeerd G.","family":"Kimman","sequence":"additional","affiliation":[{"name":"Laboratory for Vaccine-Preventable Diseases, National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720 BA Bilthoven, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1086\/315326"},{"key":"e_1_3_2_3_2","first-page":"1094","volume":"49","year":"2000","unstructured":"Centers for Disease Control and Prevention. 2000. Outbreak of poliomyelitis-Dominican Republic and Haiti, 2000. Morb. Mortal. Wkly. Rep.49:1094-1103.","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_2_4_2","first-page":"874","volume":"50","year":"2001","unstructured":"Centers for Disease Control and Prevention. 2001. Acute flaccid paralysis associated with circulating vaccine-derived poliovirus-Philippines, 2001. Morb. Mortal. Wkly. Rep.50:874-875.","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_2_5_2","first-page":"41","volume":"50","year":"2001","unstructured":"Centers for Disease Control and Prevention. 2001. Circulation of a type 2 vaccine-derived poliovirus-Egypt, 1982-1993. Morb. Mortal. Wkly. Rep.50:41-42.","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_2_6_2","first-page":"662.","volume":"51","year":"2002","unstructured":"Centers for Disease Control and Prevention. 2002. Poliomyelitis-Madagascar, 2002. Morb. Mortal. Wkly. Rep.51:662.","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_2_7_2","first-page":"253","volume":"51","year":"2002","unstructured":"Centers for Disease Control and Prevention. 2002. Progress toward global eradication of poliomyelitis, 2001. Morb. Mortal. Wkly. Rep.51:253-256.","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.13.6791-6799.2002"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-83-7-1707"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.13.5740-5751.2001"},{"key":"e_1_3_2_11_2","first-page":"397","volume":"67","year":"2001","unstructured":"Dowdle, W. R. 2001. Polio eradication: turning the dream into reality. ASM News67:397-402.","journal-title":"ASM News"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009924"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1993.1468"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.18.8434-8443.2000"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1068284"},{"key":"e_1_3_2_16_2","first-page":"17","volume":"78","year":"1993","unstructured":"Minor, P. D. 1993. Attenuation and reversion of the Sabin vaccine strains of poliovirus. Dev. Biol. Stand.78:17-26.","journal-title":"Dev. Biol. Stand."},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1987.03390100073029"},{"key":"e_1_3_2_18_2","first-page":"493","volume":"27","year":"1938","unstructured":"Reed, L. J., and H. Muench. 1938. A simple method of estimating fifty per cent end points. Am. J. Hygiene27:493-497.","journal-title":"Am. J. Hygiene"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(90)90168-E"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.38.10.3729-3734.2000"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.71.7.4915-4920.1997"}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.77.11.6541-6545.2003","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.77.11.6541-6545.2003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T07:47:51Z","timestamp":1646466471000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JVI.77.11.6541-6545.2003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,6]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2003,6]]}},"alternative-id":["10.1128\/JVI.77.11.6541-6545.2003"],"URL":"https:\/\/doi.org\/10.1128\/jvi.77.11.6541-6545.2003","relation":{},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"value":"0022-538X","type":"print"},{"value":"1098-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,6]]},"assertion":[{"value":"2002-11-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-03-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-06-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}